Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.15
0.00 (0.00%)
At close: Sep 26, 2025, 11:09 AM
0.00% (1D)
| Bid | 1.14 |
| Market Cap | 12.79M |
| Revenue (ttm) | 155.93K |
| Net Income (ttm) | -40.86M |
| EPS (ttm) | -4.87 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | 0.63 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.15 |
| Volume | 101,280 |
| Avg. Volume (20D) | 725,442 |
| Open | 1.16 |
| Previous Close | 1.15 |
| Day's Range | 1.14 - 1.16 |
| 52-Week Range | 0.65 - 13.53 |
| Beta | 1.35 |
| Ex-Dividend Date | n/a |
About CTXR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTXR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTXR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCitius Pharmaceuticals Inc. is scheduled to release its earnings on
Dec 26, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.76%
Citius Oncology and Citius Pharmaceuticals shares ...
Unlock content with
Pro Subscription
2 months ago
-8.59%
Citius Pharmaceuticals shares are trading lower after the company's subsidiary announced the pricing of a $9 million public offering.
